What is Zymeworks's EV / EBITDA?

Zymeworks (ZYME) reported EV / EBITDA of 2.2× in Q3 2023.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Zymeworks ZYME EV / EBITDA

EV / EBITDA at other companies

PfizerPFE

12.9×—

AmgenAMGN

15.9×-1.3×

AnaptysBio, Inc.ANAB

32.6×—

Stoke Therapeutics, Inc.STOK

41.5×—

TG TherapeuticsTGTX

37.5×-67.9×

Charles River LaboratoriesCRL

16.2×+2.9×

Other financials

Income statement

See full

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

See full

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

See full

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

See full

Market cap$1.76B+125%

Enterprise value$1.53B+112%

P/S21.6×+13.2×

Profitability

See full

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

See full

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Calculated from Zymeworks’s reported figures.

enterprise value/ebitda=2.2×

Based on the most recent quarter.

The official record: Zymeworks’s 10-Q, filed October 31, 2024, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zymeworks's EV / EBITDA?: Zymeworks (ZYME) reported EV / EBITDA of 2.2× in Q3 2023.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.